Transforming Clinical Trials with Generative AI: Insights from Medable
In this interview, we speak with Tim Smith, co-founder and CTO at Medable, to discuss AI’s role in addressing...
In this interview, we speak with Tim Smith, co-founder and CTO at Medable, to discuss AI’s role in addressing...
A recent virtual summit hosted by Cyntegrity focused on the pivotal role of artificial intelligence (AI) in Risk-Based Quality...
The Office for Human Research Protections (OHRP) recently hosted its 7th exploratory workshop, focusing on the increasingly pervasive topic...
This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...
Traditionally regarded as a cornerstone of global innovation, the pharmaceutical industry now faces unprecedented challenges, prompting even the largest...
Unlearn, an AI company, showcased the impact of its technology in two poster sessions at the Alzheimer’s Association International...
Clinical trials are increasingly complex, posing challenges in predicting protocol changes, managing enrollment, and ensuring data quality. Aaron Mackey,...
As a pioneer in oncological and hematological innovation, Massive Bio is showcasing its groundbreaking AI technology at the ASCO...
In a pioneering initiative, the Food and Drug Administration (FDA) has laid out a comprehensive discussion paper focusing on...